Case Study

Large Pharma Firm Leverages An AI/ML Platform To Democratize Data, Analytics, And AI

A Federated Model For AI/ML Capabilities Development

 and  four contributors
Jul 28, 2025

Summary

To drive innovation and efficiency, a leading multinational pharmaceutical and biotechnology firm implemented a unified AI/ML platform to break down data silos and unite analysts, scientists, and business users. The platform pairs governed, self-service data access; end-to-end model lineage; and flexible workbenches with interactive dashboards. This case study details how the platform — reinforced by federated data stewardship, strategic tech partnerships, and an aggressive enablement program — converted scattered assets into an engine for compliant AI deployment, faster experimentation, and measurable gains across R&D, manufacturing, and commercial operations.

Log in to continue reading
Client log in
Welcome back. Log in to your account to continue reading this research.
Become a client
Become a client today for these benefits:
  • Stay ahead of changing market and customer dynamics with the latest insights.
  • Partner with expert analysts to make progress on your top initiatives.
  • Get answers from trusted research using Izola, Forrester's genAI tool.
Purchase this report
This report is available for individual purchase ($1495).